Identification of patients with neuropathic pain using electronic
primary care records

Gajria, Camille; Murray, Joanna; Birger, Ruthie; Banarsee, Ricky; Bennett, David L.H.; Tan, Keith; Field, Mark; Rice, Andrew S.C.; Majeed, Azeem

doi:10.14236/jhi.v19i2.799

Cited by 13 publications

(19 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Neuropathic pain is a global burden. In a systematic review, van Hecke et al (2014) found that the worldwide prevalence of chronic NeP varied extensively, ranging from 1.3% (Gajria et al, 2011) to 17.9% (Toth et al, 2009). Such variation is likely because of not only the disparate areas in which the investigations were conducted but also the different sociodemographic characteristics, methods of data collection, and definitions of CP.…”

Section: Introductionmentioning

confidence: 99%

The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population

Inoue

Taguchi

Yamashita

et al. 2017

European Journal of Pain

View full text Add to dashboard Cite

BackgroundThis study marks the first epidemiological evaluation of the prevalence and burden of chronic neuropathic pain (NeP) in an Asian population. The objective of this nationwide cross‐sectional study was to identify the characteristics of individuals with NeP, detect the NeP features that affect their quality of life (QOL), and demonstrate the negative effects of NeP on social and daily living as well as comorbidities including depression, anxiety and sleep disorders.MethodsWe mailed a cross‐sectional, population‐based epidemiological survey to a random nationwide sample of 10,000 Japanese adults over 20 years old.ResultsThe response rate was 54.4% (2445 men, 2992 women; mean age, 53.4 years). Prevalence of chronic pain was 16.6%, and prevalence of NeP was 3.2% as detected by the PainDETECT. Participants with NeP showed significantly lower quality of life according to scores on the EuroQol‐5 Dimensions scale (p < 0.001), higher levels of psychological distress on the Kessler 6‐item psychological distress scale (p < 0.001), poorer sleep quality (p < 0.001), and more workdays lost (p < 0.001) than did participants without NeP. Linear regression modelling showed that widespread pain, thermal hyperalgesia and pressure‐induced pain had strong associations with lower QOL, with regression coefficients of −0.046 (p < 0.001), −0.038 (p < 0.001), and −0.040 (p < 0.001), respectively.ConclusionsThis study is the first to report the prevalence of NeP in an Asian population using a validated questionnaire. This study provides compelling evidence that chronic NeP is more strongly associated with poorer QOL, mental health and social well‐being than CP without a neuropathic component.SignificanceThis population‐based nationwide epidemiological study revealed the prevalence, characteristics, and negative effects of chronic pain with neuropathic components in Asian society. The prevalence of neuropathic pain was 3.2% with PainDETECT.

show abstract

Section: Introductionmentioning

confidence: 99%

The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population

Inoue

Taguchi

Yamashita

et al. 2017

European Journal of Pain

View full text Add to dashboard Cite

show abstract

“…Nevertheless our findings are consistent with a review of over 100,000 electronic medical records in a primary care clinic where black patients were less likely to be diagnosed with neuropathic pain than their white counterparts. 23 Again, these findings should be interpreted cautiously, since data were not separated by gender and the prevalence of neuropathic pain was low in both the black and white groups. Quantitative sensory testing, which has been performed in women with PVD, 24 should be further studied by evaluating ethnic differences in pain perception.…”

Section: Discussionmentioning

confidence: 88%

Presenting Symptoms Among Black and White Women with Provoked Vulvodynia

Brown

Foster

Bachour

et al. 2015

Journal of Women's Health

View full text Add to dashboard Cite

show abstract

“…As mentioned before, NeP appears to be better documented than PN; therefore, more epidemiological studies on the prevalence of NeP than of PN are available. While Bouhassira et al reported an overall prevalence of chronic pain with neuropathic characteristics in 6.9% of over 23,000 participants from France [25], Gajria et al found diagnoses associated with NeP in only 1.3% of over 100,000 primary care electronic records from London, UK [26]. For Japan, a cross-sectional, population-based epidemiological survey with more than 5,000 respondents led to a NeP prevalence of 3.2% [27].…”

Section: Resultsmentioning

confidence: 99%

A Review on Prevalence and Causes of Peripheral Neuropathy and Treatment of Different Etiologic Subgroups with Neurotropic B Vitamins

Hakim¹,

Kurniani²,

Pinzon³

et al. 2019

J Clin Exp Pharmacol

View full text Add to dashboard Cite

Peripheral neuropathy (PN) is the most common disorder of the peripheral nervous system in adults, and its prevalence increases with age. Because PN is often poorly documented and strongly underdiagnosed, estimating its prevalence in the general population is difficult. Only few epidemiological studies on the prevalence of PN in the general population are available, mostly from industrialized countries. Especially in developing countries, figures from different sources vary considerably. Available data often focus on certain etiological subgroups-particularly diabetics-or on neuropathic pain (NeP), which contributes to this variation. More epidemiological prevalence studies from the general population are required to gain a better picture on sizes of patient groups and cause patterns. To provide an overview of current prevalence data, we performed a selective literature search in PubMed, Cochrane and Google Scholar and used relevant examples along with comprehensive reviews covering the past 15+ years identified through the use of the authors' own files. These data indicate that PN is frequent and often undiagnosed for a long time.Although diabetes is the number one cause of PN worldwide, there are various causes beyond, making it hard for physicians to gain a clear patient picture and recognize symptoms. Most clinical studies also focus on diabetic PN treatment only; thus, data comparing the treatment of PN of several etiologies are rare, which contributes to the lack of awareness of PN causes. In order to demonstrate that different PN subgroups can benefit from treatment with B vitamins progressively over time-regardless of underlying PN causes, we also present some subgroup results of a recent non-interventional study (Neurobion non-interventional; NENOIN) herein. The NENOIN study showed that treating PN of different etiologies including idiopathic neuropathy is possible with a fixed dose of neurotropic B vitamins. Therefore, we conclude that this is an effective treatment option for different PN subgroups from which even patients with unknown PN causes can benefit.

show abstract

Identification of patients with neuropathic pain using electronic primary care records

Cited by 13 publications

References 17 publications

The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population

The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population

Presenting Symptoms Among Black and White Women with Provoked Vulvodynia

A Review on Prevalence and Causes of Peripheral Neuropathy and Treatment of Different Etiologic Subgroups with Neurotropic B Vitamins

Contact Info

Product

Resources

About